Manuscript
Estimating the risk of cardiovascular outcomes and all-cause mortality in individuals with type 2 diabetes: Validation of the UKPDS Outcomes Model using TECOS and EXSCEL data
Coleman RL et al.
Diabetes Obes Metab. 2025
Manuscript
International Variation in Case Fatality After Major Coronary or Cerebrovascular Events in Individuals With Type 2 Diabetes: Evidence From ADVANCE, TECOS, and EXSCEL
Philip M Clarke et al.
Diabetes Care 2025;48:1925-1931
Manuscript
Utilization of proteomic surrogates for early detection of unexpected drug benefits
Jessica Chadwick et al.
J Clin Pharmacol. 2025;65:1460-1473
Manuscript
Impact of changes in conventional risk factors induced by once-weekly GLP-1 receptor agonist exenatide on cardiovascular outcomes: an EXSCEL post hoc analysis
Ruth L Coleman et al.
Cardiovasc Diabetol. 2025;24:347
Manuscript
Proteomic Pathways across Ejection Fraction Spectrum in Heart Failure: an EXSCEL Substudy
Anthony E. Peters et al.
Sci Rep 2025;15:30170
Manuscript
Evaluating prediction of short-term tolerability of five type 2 diabetes drug classes using routine clinical features: UK population-based study
Pedro Cardoso et al.
Diabetes Obes Metab. 2025;27:4320-4329